Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes-Reference-Cited by-同舟云学术

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes

Author:

Chilton R.¹,Tikkanen I.²,Cannon C. P.³,Crowe S.⁴,Woerle H. J.⁴,Broedl U. C.⁴,Johansen O. E.⁵

Affiliation:

1. Department of Medicine University of Texas Health Science Center San Antonio TX USA

2. Helsinki University Hospital and Minerva Institute for Medical Research, University of Helsinki Helsinki Finland

3. Department of Cardiology Harvard Clinical Research Institute Boston MA USA

4. Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Germany

5. Boehringer Ingelheim Norway KS Asker Norway

Funder

Boehringer Ingelheim

Eli Lilly and Company

GlaxoSmithKline

Merck

Takeda Pharmaceuticals U.S.A.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference45 articles.

1. Standards of medical care in diabetes‐2015;American Diabetes Association;Diabetes Care,2015

Cited by 406 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献